In contrast, CDK5 was rarely mutated among cancers and, more importantly, was never mutated in CRC, indicating that CDK5’s contribution to CRC oncogenesis was due to its high expression rather than mutation [13]. The gene discussed is CDK5; the disease is colorectal carcinoma.